9.35
price down icon1.89%   -0.18
after-market After Hours: 9.20 -0.15 -1.60%
loading
Niagen Bioscience Inc stock is traded at $9.35, with a volume of 753.45K. It is down -1.89% in the last 24 hours and down -35.11% over the past month. Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
See More
Previous Close:
$9.53
Open:
$9.54
24h Volume:
753.45K
Relative Volume:
0.71
Market Cap:
$736.50M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.86%
1M Performance:
-35.11%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
Value
$9.22
$9.6066
1-Week Range:
Value
$9.21
$9.96
52-Week Range:
Value
$5.33
$14.69

Niagen Bioscience Inc Stock (NAGE) Company Profile

Name
Name
Niagen Bioscience Inc
Name
Phone
310-388-6706
Name
Address
10900 WILSHIRE BLVD, LOS ANGELES
Name
Employee
104
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
NAGE's Discussions on Twitter

Compare NAGE with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
NAGE
Niagen Bioscience Inc
9.35 750.67M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
456.87 120.48B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
545.46 59.88B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
392.24 44.31B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
670.33 36.65B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
301.13 32.46B 3.81B -644.79M -669.77M -6.24

Niagen Bioscience Inc Stock (NAGE) Upgrades & Downgrades

Date Action Analyst Rating Change
May-27-25 Initiated Canaccord Genuity Buy
Aug-16-22 Downgrade Oppenheimer Outperform → Perform
Aug-11-22 Downgrade B. Riley Securities Buy → Neutral
Mar-08-22 Initiated ROTH Capital Buy
Oct-16-19 Initiated Oppenheimer Outperform
Feb-14-19 Initiated B. Riley FBR Buy
Nov-27-17 Resumed H.C. Wainwright Buy
Sep-25-17 Initiated Ladenburg Thalmann Buy
Jan-03-17 Initiated Rodman & Renshaw Buy
View All

Niagen Bioscience Inc Stock (NAGE) Latest News

pulisher
Jul 31, 2025

Is Niagen Bioscience Inc. a growth stock or a value stockFinancial News Tracker With High Returns - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 31, 2025

How strong is Niagen Bioscience Inc. company’s balance sheetReal Time Watchlist To Watch Now - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 31, 2025

Real time scanner hits for Niagen Bioscience Inc. explainedRisk Managed Intraday Trade Alerts Increase in Volume - metal.it

Jul 31, 2025
pulisher
Jul 30, 2025

What technical models suggest about Niagen Bioscience Inc.’s comebackChart Driven High Reward Trading Setup Presented - metal.it

Jul 30, 2025
pulisher
Jul 30, 2025

Niagen Bioscience And Two Other High Growth Stocks With Strong Insider Ownership - Yahoo Finance

Jul 30, 2025
pulisher
Jul 29, 2025

Niagen Bioscience Subsidiary Signs Supply Agreement - TipRanks

Jul 29, 2025
pulisher
Jul 29, 2025

Niagen Bioscience (NASDAQ:NAGE) Trading 6% HigherWhat's Next? - MarketBeat

Jul 29, 2025
pulisher
Jul 29, 2025

Bollinger Band Squeeze Points to Volatility in Niagen Bioscience Inc.Short Term Buy Zone Stock Alerts Signal Entry - beatles.ru

Jul 29, 2025
pulisher
Jul 28, 2025

Can Niagen Bioscience Inc. hit a new high this monthHigh Yield Stock Screening Results Explained - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

What makes Niagen Bioscience Inc. stock price move sharplyWeekly Growth Stock Entry Point Alerts Highlighted - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Why is Niagen Bioscience Inc. stock attracting strong analyst attentionAdvanced Screener Report With Low Risk - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Niagen Bioscience Inc. May Be Forming Higher Low — Chartwatchers AlertMarket Momentum Signal Generator Shows Trends - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

What is the dividend policy of Niagen Bioscience Inc. stockExceptional gains - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What is Niagen Bioscience Inc. company’s growth strategyAchieve rapid wealth accumulation through smart investing - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

Should I hold or sell Niagen Bioscience Inc. stock in 2025Invest confidently with professional guidance - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How does Niagen Bioscience Inc. generate profit in a changing economyMaximize your investment portfolio’s performance - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 25, 2025

Niagen Bioscience Inc. Stock Analysis and ForecastHigh-yield capital appreciation - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What drives Niagen Bioscience Inc. stock priceFree Market Volatility Navigation Tips - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 24, 2025

Does Niagen Bioscience Inc. stock pay reliable dividendsTriple-digit return opportunities - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

Is Niagen Bioscience Inc. a good long term investmentOutstanding growth strategies - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

Niagen Bioscience, Inc.'s (NASDAQ:NAGE) Stock Is Going Strong: Is the Market Following Fundamentals? - Yahoo Finance

Jul 24, 2025
pulisher
Jul 23, 2025

Niagen Bioscience to Report Second Quarter 2025 Financial Result - GuruFocus

Jul 23, 2025
pulisher
Jul 23, 2025

Niagen Bioscience to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025 - Business Wire

Jul 23, 2025
pulisher
Jul 23, 2025

Niagen Bioscience, Inc.'s (NASDAQ:NAGE) market cap dropped US$129m last week; individual investors who hold 33% were hit as were institutions - simplywall.st

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Niagen Bioscience Inc. stockFree Consultation - Autocar Professional

Jul 23, 2025
pulisher
Jul 21, 2025

Niagen Bioscience Shares Climb Following Exclusive License for Parkinson’s Therapy - MSN

Jul 21, 2025
pulisher
Jul 21, 2025

Niagen Bioscience (NASDAQ:NAGE) Shares Down 4%Time to Sell? - MarketBeat

Jul 21, 2025
pulisher
Jul 17, 2025

Niagen Bioscience, Inc. (NASDAQ:NAGE) Receives Average Rating of "Buy" from Brokerages - MarketBeat

Jul 17, 2025
pulisher
Jul 17, 2025

Analysts Set Niagen Bioscience, Inc. (NASDAQ:NAGE) Target Price at $13.22 - Defense World

Jul 17, 2025

Niagen Bioscience Inc Stock (NAGE) Financials Data

There is no financial data for Niagen Bioscience Inc (NAGE). Check out other stocks for more information.

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$74.89
price down icon 3.43%
$36.80
price down icon 0.86%
$107.28
price up icon 2.00%
$26.37
price down icon 1.09%
$107.50
price down icon 2.32%
biotechnology ONC
$301.13
price up icon 0.40%
Cap:     |  Volume (24h):